Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients

A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research : BCR 2012-03, Vol.14 (2), p.R51-R51, Article R51
Hauptverfasser: Román-Pérez, Erick, Casbas-Hernández, Patricia, Pirone, Jason R, Rein, Jessica, Carey, Lisa A, Lubet, Ronald A, Mani, Sendurai A, Amos, Keith D, Troester, Melissa A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R51
container_issue 2
container_start_page R51
container_title Breast cancer research : BCR
container_volume 14
creator Román-Pérez, Erick
Casbas-Hernández, Patricia
Pirone, Jason R
Rein, Jessica
Carey, Lisa A
Lubet, Ronald A
Mani, Sendurai A
Amos, Keith D
Troester, Melissa A
description A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance. Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-β)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes. Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-β induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear
doi_str_mv 10.1186/bcr3152
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3446385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A286975799</galeid><sourcerecordid>A286975799</sourcerecordid><originalsourceid>FETCH-LOGICAL-b590t-7b630ec99dbd1c8ed30831e496efe3b6cf354ed18dcb9a048c23d28eefdd144b3</originalsourceid><addsrcrecordid>eNqFkl1rFDEUhoNYbK3iP5ABL-rN1nzOJF4IpWgtFLxR8C7k40yNzCRrkin235t117ILiuQiH-d538M5Jwi9IPicENm_sS4zIugjdEJ4L1aC06-P987H6Gkp3zEmgxTyCTqmlFPFe3aC_BVE6ODnOkMpIcUuxHar2dRlTtlM3RxcThDvQk5xhli7RvrgauncFGJwDUlLdWmGjdRmMKV2zkQHuVubGpqkPENHo5kKPN_tp-jLh_efLz-ubj5dXV9e3KysULiuBtszDE4pbz1xEjzDkhHgqocRmO3dyAQHT6R3VhnMpaPMUwkwek84t-wUvdv6rhc7g3ctdytBr3OYTb7XyQR9GInhm75Nd5rx1gwpmsHbrYEN6R8Gh5FWt971volf77Ln9GOBUvUcioNpMhHSUjQZBGsYJfj_KOaEUY6VauirLXprJtAhjqkldhtcX1DZq0EMv6nzv1BteWgDTBHG0N4PBGdbQZtuKRnGhyIJ1psvtVfWy_2mPnB__hD7BSVsyzs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1041324099</pqid></control><display><type>article</type><title>Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Román-Pérez, Erick ; Casbas-Hernández, Patricia ; Pirone, Jason R ; Rein, Jessica ; Carey, Lisa A ; Lubet, Ronald A ; Mani, Sendurai A ; Amos, Keith D ; Troester, Melissa A</creator><creatorcontrib>Román-Pérez, Erick ; Casbas-Hernández, Patricia ; Pirone, Jason R ; Rein, Jessica ; Carey, Lisa A ; Lubet, Ronald A ; Mani, Sendurai A ; Amos, Keith D ; Troester, Melissa A</creatorcontrib><description>A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance. Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-β)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes. Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-β induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear staining, predominantly in epithelium, and no evidence of increased fibrosis. These results document the presence of two distinct subtypes of microenvironment, with Active versus Inactive cancer-adjacent extratumoral microenvironment influencing the aggressiveness and outcome of ER-positive human breast cancers.</description><identifier>ISSN: 1465-542X</identifier><identifier>ISSN: 1465-5411</identifier><identifier>EISSN: 1465-542X</identifier><identifier>DOI: 10.1186/bcr3152</identifier><identifier>PMID: 22429463</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Breast cancer ; Breast Neoplasms - genetics ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Carcinoma, Intraductal, Noninfiltrating - genetics ; Carcinoma, Intraductal, Noninfiltrating - mortality ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Claudins - genetics ; Female ; Fibroblasts - pathology ; Fibrosis - genetics ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genetic aspects ; Humans ; Identification and classification ; Kaplan-Meier Estimate ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; Prognosis ; Receptors, Estrogen - genetics ; Receptors, Estrogen - metabolism ; Transforming Growth Factor beta - genetics ; Transforming Growth Factor beta - metabolism ; Tumor Microenvironment - genetics ; Twist-Related Protein 1 - genetics ; Twist-Related Protein 1 - metabolism</subject><ispartof>Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R51-R51, Article R51</ispartof><rights>COPYRIGHT 2012 BioMed Central Ltd.</rights><rights>Copyright ©2012 Román-Pérez et al.; licensee BioMed Central Ltd. 2012 Román-Pérez et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b590t-7b630ec99dbd1c8ed30831e496efe3b6cf354ed18dcb9a048c23d28eefdd144b3</citedby><cites>FETCH-LOGICAL-b590t-7b630ec99dbd1c8ed30831e496efe3b6cf354ed18dcb9a048c23d28eefdd144b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446385/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446385/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22429463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Román-Pérez, Erick</creatorcontrib><creatorcontrib>Casbas-Hernández, Patricia</creatorcontrib><creatorcontrib>Pirone, Jason R</creatorcontrib><creatorcontrib>Rein, Jessica</creatorcontrib><creatorcontrib>Carey, Lisa A</creatorcontrib><creatorcontrib>Lubet, Ronald A</creatorcontrib><creatorcontrib>Mani, Sendurai A</creatorcontrib><creatorcontrib>Amos, Keith D</creatorcontrib><creatorcontrib>Troester, Melissa A</creatorcontrib><title>Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients</title><title>Breast cancer research : BCR</title><addtitle>Breast Cancer Res</addtitle><description>A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance. Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-β)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes. Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-β induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear staining, predominantly in epithelium, and no evidence of increased fibrosis. These results document the presence of two distinct subtypes of microenvironment, with Active versus Inactive cancer-adjacent extratumoral microenvironment influencing the aggressiveness and outcome of ER-positive human breast cancers.</description><subject>Breast cancer</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma, Intraductal, Noninfiltrating - genetics</subject><subject>Carcinoma, Intraductal, Noninfiltrating - mortality</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Claudins - genetics</subject><subject>Female</subject><subject>Fibroblasts - pathology</subject><subject>Fibrosis - genetics</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Kaplan-Meier Estimate</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>Prognosis</subject><subject>Receptors, Estrogen - genetics</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Transforming Growth Factor beta - genetics</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Tumor Microenvironment - genetics</subject><subject>Twist-Related Protein 1 - genetics</subject><subject>Twist-Related Protein 1 - metabolism</subject><issn>1465-542X</issn><issn>1465-5411</issn><issn>1465-542X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl1rFDEUhoNYbK3iP5ABL-rN1nzOJF4IpWgtFLxR8C7k40yNzCRrkin235t117ILiuQiH-d538M5Jwi9IPicENm_sS4zIugjdEJ4L1aC06-P987H6Gkp3zEmgxTyCTqmlFPFe3aC_BVE6ODnOkMpIcUuxHar2dRlTtlM3RxcThDvQk5xhli7RvrgauncFGJwDUlLdWmGjdRmMKV2zkQHuVubGpqkPENHo5kKPN_tp-jLh_efLz-ubj5dXV9e3KysULiuBtszDE4pbz1xEjzDkhHgqocRmO3dyAQHT6R3VhnMpaPMUwkwek84t-wUvdv6rhc7g3ctdytBr3OYTb7XyQR9GInhm75Nd5rx1gwpmsHbrYEN6R8Gh5FWt971volf77Ln9GOBUvUcioNpMhHSUjQZBGsYJfj_KOaEUY6VauirLXprJtAhjqkldhtcX1DZq0EMv6nzv1BteWgDTBHG0N4PBGdbQZtuKRnGhyIJ1psvtVfWy_2mPnB__hD7BSVsyzs</recordid><startdate>20120319</startdate><enddate>20120319</enddate><creator>Román-Pérez, Erick</creator><creator>Casbas-Hernández, Patricia</creator><creator>Pirone, Jason R</creator><creator>Rein, Jessica</creator><creator>Carey, Lisa A</creator><creator>Lubet, Ronald A</creator><creator>Mani, Sendurai A</creator><creator>Amos, Keith D</creator><creator>Troester, Melissa A</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20120319</creationdate><title>Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients</title><author>Román-Pérez, Erick ; Casbas-Hernández, Patricia ; Pirone, Jason R ; Rein, Jessica ; Carey, Lisa A ; Lubet, Ronald A ; Mani, Sendurai A ; Amos, Keith D ; Troester, Melissa A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b590t-7b630ec99dbd1c8ed30831e496efe3b6cf354ed18dcb9a048c23d28eefdd144b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Breast cancer</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma, Intraductal, Noninfiltrating - genetics</topic><topic>Carcinoma, Intraductal, Noninfiltrating - mortality</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Claudins - genetics</topic><topic>Female</topic><topic>Fibroblasts - pathology</topic><topic>Fibrosis - genetics</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Kaplan-Meier Estimate</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>Prognosis</topic><topic>Receptors, Estrogen - genetics</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Transforming Growth Factor beta - genetics</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Tumor Microenvironment - genetics</topic><topic>Twist-Related Protein 1 - genetics</topic><topic>Twist-Related Protein 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Román-Pérez, Erick</creatorcontrib><creatorcontrib>Casbas-Hernández, Patricia</creatorcontrib><creatorcontrib>Pirone, Jason R</creatorcontrib><creatorcontrib>Rein, Jessica</creatorcontrib><creatorcontrib>Carey, Lisa A</creatorcontrib><creatorcontrib>Lubet, Ronald A</creatorcontrib><creatorcontrib>Mani, Sendurai A</creatorcontrib><creatorcontrib>Amos, Keith D</creatorcontrib><creatorcontrib>Troester, Melissa A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research : BCR</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Román-Pérez, Erick</au><au>Casbas-Hernández, Patricia</au><au>Pirone, Jason R</au><au>Rein, Jessica</au><au>Carey, Lisa A</au><au>Lubet, Ronald A</au><au>Mani, Sendurai A</au><au>Amos, Keith D</au><au>Troester, Melissa A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients</atitle><jtitle>Breast cancer research : BCR</jtitle><addtitle>Breast Cancer Res</addtitle><date>2012-03-19</date><risdate>2012</risdate><volume>14</volume><issue>2</issue><spage>R51</spage><epage>R51</epage><pages>R51-R51</pages><artnum>R51</artnum><issn>1465-542X</issn><issn>1465-5411</issn><eissn>1465-542X</eissn><abstract>A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance. Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-β)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes. Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-β induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear staining, predominantly in epithelium, and no evidence of increased fibrosis. These results document the presence of two distinct subtypes of microenvironment, with Active versus Inactive cancer-adjacent extratumoral microenvironment influencing the aggressiveness and outcome of ER-positive human breast cancers.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>22429463</pmid><doi>10.1186/bcr3152</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-542X
ispartof Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R51-R51, Article R51
issn 1465-542X
1465-5411
1465-542X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3446385
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Carcinoma, Intraductal, Noninfiltrating - genetics
Carcinoma, Intraductal, Noninfiltrating - mortality
Carcinoma, Intraductal, Noninfiltrating - pathology
Claudins - genetics
Female
Fibroblasts - pathology
Fibrosis - genetics
Gene expression
Gene Expression Regulation, Neoplastic
Genetic aspects
Humans
Identification and classification
Kaplan-Meier Estimate
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Prognosis
Receptors, Estrogen - genetics
Receptors, Estrogen - metabolism
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - metabolism
Tumor Microenvironment - genetics
Twist-Related Protein 1 - genetics
Twist-Related Protein 1 - metabolism
title Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T17%3A00%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene%20expression%20in%20extratumoral%20microenvironment%20predicts%20clinical%20outcome%20in%20breast%20cancer%20patients&rft.jtitle=Breast%20cancer%20research%20:%20BCR&rft.au=Rom%C3%A1n-P%C3%A9rez,%20Erick&rft.date=2012-03-19&rft.volume=14&rft.issue=2&rft.spage=R51&rft.epage=R51&rft.pages=R51-R51&rft.artnum=R51&rft.issn=1465-542X&rft.eissn=1465-542X&rft_id=info:doi/10.1186/bcr3152&rft_dat=%3Cgale_pubme%3EA286975799%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1041324099&rft_id=info:pmid/22429463&rft_galeid=A286975799&rfr_iscdi=true